New guidelines of the European society of hypertension

被引：0
作者：
Julian Segura
Luis M. Ruilope
机构：
[1] Hospital 12 de Octubre,Hypertension Unit
来源：
Current Hypertension Reports | 2008年 / 10卷
关键词：
Ramipril; Candesartan; Telmisartan; Indapamide; Benazepril;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 338
页数：1
相关论文
共 41 条
[31]   The effect of antihypertensive agents on new-onset diabetes mellitus: Time to amend the guidelines? [J].
Aksnes T.A. ;
Kjeldsen S.E. ;
Mancia G. .
American Journal of Cardiovascular Drugs, 2006, 6 (3) :139-147
[32]   COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK [J].
Martsevich, S. Yu. ;
Lukina, Yu. V. ;
Dmitrieva, N. A. ;
Lerman, O. V. ;
Tolpygina, S. N. ;
Serazhim, A. A. ;
Voronina, V. P. ;
Maksimova, M. A. ;
Drozdova, L. Yu. ;
Zakharova, A. V. .
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (01) :20-28
[33]   Central blood pressure, arterial stiffness, and wave reflection: New targets of treatment in essential hypertension [J].
Lorenzo Ghiadoni ;
Rosa Maria Bruno ;
Francesco Stea ;
Agostino Virdis ;
Stefano Taddei .
Current Hypertension Reports, 2009, 11 :190-196
[34]   A new Febuxostat-Telmisartan Drug-Drug Cocrystal for Gout-Hypertension Combination Therapy [J].
Ganesan, Thipashini ;
Muthudoss, Prakash ;
Voguri, Raja Sekhar ;
Ghosal, Subhas ;
Ann, Eddy Yii Chung ;
Kwok, Jayson ;
Shahnawaz, Sajid Syed ;
Omar, Muhammad Firdaus ;
Allada, Ravikiran ;
See, Hong Heng .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (12) :3318-3326
[35]   SYSTEMIC AND RENAL EFFECTS OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, BENAZEPRIL, IN ESSENTIAL-HYPERTENSION [J].
VALVO, E ;
CASAGRANDE, P ;
BEDOGNA, V ;
ANTIGA, L ;
ALBERTI, D ;
ZAMBONI, M ;
PEROBELLI, L ;
DALSANTO, F ;
MASCHIO, G .
JOURNAL OF HYPERTENSION, 1990, 8 (11) :991-995
[36]   New Insights into the Management of Hypertension and Cardiovascular Risk with Angiotensin Receptor Blockers: Observational Studies Help Us? [J].
Goudev, Assen .
OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2014, 8 :35-42
[37]   Long-Term Control of Ambulatory Hypertension in Children: Improving With Time But Still Not Achieving New Blood Pressure Goals [J].
Seeman, Tomas ;
Gilik, Jiri .
AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (07) :939-945
[38]   Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [J].
Omboni, Stefano ;
Malacco, Ettore ;
Mallion, Jean-Michel ;
Volpe, Massimo .
CLINICAL INTERVENTIONS IN AGING, 2015, 10 :1575-1586
[39]   EFFICACY AND SAFETY OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, RAMIPRIL, VS ENALAPRIL IN ESSENTIAL-HYPERTENSION - A MULTICENTER TRIAL [J].
MROCZEK, WJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 :S147-S149
[40]   THE EFFECT OF RAMIPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ON CORTICAL NEPHRON FLOW AND EFFECTIVE RENAL PLASMA-FLOW IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
ALNAHHAS, AM ;
NIMMON, CC ;
BRITTON, KE ;
CARROLL, MJ ;
ALJANABI, MA ;
SOLANKI, K ;
BOMANJI, J .
NEPHRON, 1990, 54 (01) :47-&
12345